Printed from Voxsanity (voxsanity.com.au) — NCT07642518 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Type 2 Diabetes
Type 2 Diabetes Trial, Not Yet Recruiting
NCT07642518
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with type 2 diabetes.
- People who meet the medical criteria for mild cognitive impairment (early-stage memory or thinking difficulties that are more than normal aging but not dementia).
- People aged between 40 and 75 years old, of any gender.
- People whose HbA1c (a blood test measuring average blood sugar levels over roughly 3 months) is between 6.5% and 9.0%.
- People who have completed at least 6 years of formal schooling.
- People who are able to participate in and finish all memory, thinking, and daily functioning tests required by the trial.
- People who are right-handed.
- People who are willing to give written consent to participate voluntarily.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have used certain medications in the 3 months before screening, including GLP-1 receptor agonist drugs (a type of diabetes medication), Alzheimer's disease medications, anti-Parkinson's medications, epilepsy medications, or antipsychotic medications.
- People who have dementia, or who have had a significant psychiatric condition (such as schizophrenia, bipolar disorder, major depression, generalised anxiety disorder, or personality disorders) in the past 2 years.
- People who have a brain or nervous system disease, such as a traumatic brain injury, bleeding in the brain, or a recent stroke.
- People with severe sinus problems, nasal or sinus polyps, certain tumours near the skull base or throat, a history of injury or birth-related conditions affecting the nose or skull that impact the sense of smell, or people who have cold or upper respiratory symptoms (such as a blocked nose, runny nose, or fever) on the day of their MRI scan.
- People who have had serious short-term diabetes complications such as diabetic ketoacidosis, a dangerous high blood sugar episode, or loss of consciousness due to low blood sugar.
- People with serious problems affecting the heart, liver, or kidneys — including certain abnormal liver test results, reduced kidney function below a set threshold, or a history within the past 3 months of unstable chest pain, heart attack, or moderate-to-severe heart failure (confirm with trial site for specific thresholds).
- People who have a serious ongoing illness alongside their other conditions, such as an active or untreated cancer, or a cancer that has been in remission for less than 5 years.
- People who cannot have an MRI scan — for example, due to metal implants in the body, severe claustrophobia (fear of enclosed spaces), a pacemaker or other implanted medical device, or a serious skin infection or ulcer around the ear.
- People who are pregnant or currently breastfeeding.
- People with a history of heavy alcohol use, defined as drinking more than 21 units of alcohol per week on average for males, or more than 14 units per week on average for females (where 1 unit equals approximately 360 mL of beer, 150 mL of wine, or 45 mL of spirits).
- People who have any other condition or circumstance that, in the trial doctor's judgement, could interfere with the safety or results of the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Registry
ClinicalTrials.gov
Start date
20 May 2026
Est. completion
31 December 2027
Primary endpoints
Montreal Cognitive Assessment Scale (MoCA) score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.